PLC-β1 knockout mice as a model of disrupted cortical development and plasticity: Behavioral endophenotypes and dysregulation of RGS4 gene expression

Hippocampus

Volumn 18, Issue 8, 2008, Pages 824-834

  McOmish, Caitlin E ^a   Burrows, Emma L ^a   Howard, Monique ^a   Hannan, Anthony J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Hippocampus; Neocortex; Neurodevelopment; Phospholipase C 1; Regulator of G protein signaling 4

Indexed keywords

MESSENGER RNA; PHOSPHOLIPASE C BETA1; PHOSPHOLIPASE C BETA; PLCB1 PROTEIN, MOUSE; PRIMER DNA; RGS PROTEIN; RGS4 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN MATURATION; CONDITIONING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; SCHIZOPHRENIA; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; FEAR; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MEMORY; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PERCEPTIVE DISCRIMINATION; PHYSIOLOGY;

ANIMALS; ANXIETY; BASE SEQUENCE; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CONDITIONING (PSYCHOLOGY); DNA PRIMERS; FEAR; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PHOSPHOLIPASE C BETA; RGS PROTEINS; RNA, MESSENGER; SCHIZOPHRENIA; SIGNAL DETECTION (PSYCHOLOGY);

EID: 50249118640     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20443     Document Type: Article

References (103)

1. Bannerman DM, Deacon RM, Offen S, Friswell J, Grubb M, Rawlins JN. 2002a. Double dissociation of function within the hippocampus: spatial memory and hyponeophagia. Behav Neurosci 116:884-901.
2. Bannerman DM, Grubb M, Deacon RM, Yee BK, Feldon J, Rawlins JN. 2003. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res 139:197-213.
3. Bannerman DM, Lemaire M, Yee BK, Iversen SD, Oswald CJ, Good MA, Rawlins JN. 2002b. Selective cytotoxic lesions of the retrohippocampal region produce a mild deficit in social recognition memory. Exp Brain Res 142:395-401.
4. Bannerman DM, Yee BK, Good MA, Heupel MJ, Iversen SD, Rawlins JN. 1999. Double dissociation of function within the hippocampus: A comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. Behav Neurosci 113:1170-1188.
5. Bast T, Zhang WN, Feldon J. 2001. The ventral hippocampus and fear conditioning in rats. Different anterograde amnesias of fear after tetrodotoxin inactivation and infusion of the GABA(A) agonist muscimol. Exp Brain Res 139:39-52.
6. Bennett JP Jr, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH. 1979. Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 36:927-934.
7. Bohm D, Schwegler H, Kotthaus L, Nayernia K, Rickmann M, Kohler M, Rosenbusch J, Engel W, Flugge G, Burfeind P. 2002. Disruption of PLC-beta 1-mediated signal transduction in mutant mice causes age-dependent hippocampal mossy fiber sprouting and neurodegeneration. Mol Cell Neurosci 21:584-601.
8. Bouwknecht JA, Paylor R. 2002. Behavioral and physiological mouse assays for anxiety: A survey in nine mouse strains. Behav Brain Res 136:489-501.
9. Braff DL, Geyer MA. 1990. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47:181-188.
10. Braff DL, Grillon C, Geyer MA. 1992. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49: 206-215.
11. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS. 2000. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678-682.
12. Carola V, D'Olimpio F, Brunamonti E, Mangia F, Renzi P. 2002. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res 134:49-57.
13. Carter C, Robertson L, Nordahl T, Chaderjian M, Kraft L, O'Shora-Celaya L. 1996. Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients. Biol Psychiatry 40:930-932.
14. Carter HR, Wallace MA, Fain JN. 1990. Activation of phospholipase C in rabbit brain membranes by carbachol in the presence of GTP gamma S; effects of biological detergents. Biochim Biophys Acta 1054:129-135.
15. Cassel JC, Cassel S, Galani R, Kelche C, Will B, Jarrard L. 1998. Fimbria-fornix vs selective hippocampal lesions in rats: effects on locomotor activity and spatial learning and memory. Neurobiol Learn Mem 69:22-45.
16. Chen X, Dunham C, Kendler S, Wang X, O'Neill FA, Walsh D, Kendler KS. 2004. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet 129:23-26.
17. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, B KT, Ferrell RE, Middleton FA, Devlin B, Levitt P, Lewis DA, Nimgaonkar VL. 2002. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11:1373-1380.
18. Cordeiro Q, Talkowski ME, Chowdari KV, Wood J, Nimgaonkar V, Vallada H. 2005. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav 4:45-50.
19. Cousens G, Otto T. 1998. Both pre- and posttraining excitotoxic lesions of the basolateral amygdala abolish the expression of olfactory and contextual fear conditioning. Behav Neurosci 112:1092-1103.
20. Crawley JN, Paylor R. 1997. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav 31:197-211.
21. Creese I, Burt DR, Snyder SH. 1976. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
22. Deacon RM, Bannerman DM, Rawlins JN. 2002. Anxiolytic effects of cytotoxic hippocampal lesions in rats. Behav Neurosci 116:494-497.
23. Dean B, Crook JM, Opeskin K, Hill C, Keks N, Copolov DL. 1996. The density of muscarinic M1 receptors is decreased in the caudateputamen of subjects with schizophrenia. Mol Psychiatry 1:54-58.
24. Desmedt A, Garcia R, Jaffard R. 1998. Differential modulation of changes in hippocampal-septal synaptic excitability by the amygdala as a function of either elemental or contextual fear conditioning in mice. J Neurosci 18:480-487.
25. Dowal L, Elliott J, Popov S, Wilkie TM, Scarlata S. 2001. Determination of the contact energies between a regulator of G protein signaling and G protein subunits and phospholipase C beta 1. Biochemistry 40:414-421.
26. Druey KM, Sullivan BM, Brown D, Fischer ER, Watson N, Blumer KJ, Gerfen CR, Scheschonka A, Kehrl JH. 1998. Expression of GTPase-deficient Gialpha2 results in translocation of cytoplasmic RGS4 to the plasma membrane. J Biol Chem 273:18405-18410.
27. Ebert PJ, Campbell DB, Levitt P. 2006a. Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex. Neuroscience 142:1145-1161.
28. Ebert PJ, Campbell DB, Levitt P. 2006b. Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. II. Subcortical regions. Neuroscience 142:1163-1181.
29. Emilsson L, Saetre P, Jazin E. 2006. Low mRNA levels of RGS4 splice variants in Alzheimer's disease: Association between a rare haplotype and decreased mRNA expression. Synapse 59:173-176.
30. Erdely HA, Tamminga CA, Roberts RC, Vogel MW. 2006. Regional alterations in RGS4 protein in schizophrenia. Synapse 59:472-479.
31. File SE. 1996. Recent developments in anxiety, stress, and depression. Pharmacol Biochem Behav 54:3-12.
32. Fleming K, Goldberg TE, Binks S, Randolph C, Gold JM, Weinberger DR. 1997. Visuospatial working memory in patients with schizophrenia. Biol Psychiatry 41:43-49.
33. Flores G, Silva-Gomez AB, Barbeau D, Srivastava LK, Zamudio S, de La Cruz Lopez F. 2005. Effect of excitotoxic lesions of the neonatal ventral hippocampus on the immobility response in rats. Life Sci 76:2339-2348.
34. Garnier M, Zaratin PF, Ficalora G, Valente M, Fontanella L, Rhee MH, Blumer KJ, Scheideler MA. 2003. Up-regulation of regulator
35. of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine. J Pharmacol Exp Ther 304:1299-1306.
36. Gogos A, Kusljic S, van den Buuse M. 2005. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Pharmacol Biochem Behav 81:664-672.
37. Gold SJ, Heifets BD, Pudiak CM, Potts BW, Nestler EJ. 2002. Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizures. J Neurochem 82:828-838.
38. Gold SJ, Ni YG, Dohlman HG, Nestler EJ. 1997. Regulators of G-protein signaling (RGS) proteins: Region-specific expression of nine subtypes in rat brain. J Neurosci 17:8024-8037.
39. Gray JA, Joseph MH, Hemsley DR, Young AM, Warburton EC, Boulenguez P, Grigoryan GA, Peters SL, Rawlins JN, Taib CT, others. 1995. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: Implications for schizophrenia. Behav Brain Res 71:19-31.
40. Grossberg S. 2000. The imbalanced brain: from normal behavior to schizophrenia. Biol Psychiatry 48:81-98.
41. Gunnersen JM, Augustine C, Spirkoska V, Kim M, Brown M, Tan SS. 2002. Global analysis of gene expression patterns in developing mouse neocortex using serial analysis of gene expression. Mol Cell Neurosci 19:560-573.
42. Hannan AJ, Blakemore C, Katsnelson A, Vitalis T, Huber KM, Bear M, Roder J, Kim D, Shin HS, Kind PC. 2001. PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. Nat Neurosci 4:282-288.
43. Hannan AJ, Kind PC, Blakemore C. 1998. Phospholipase C-beta1 expression correlates with neuronal differentiation and synaptic plasticity in rat somatosensory cortex. Neuropharmacology 37:593-605.
44. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:40-68.
45. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RL, Olson JM, Jones L, Luthi-Carter R. 2006. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15:965-977.
46. Killcross S, Robbins TW, Everitt BJ. 1997. Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 388:377-380.
47. Kim D, Jun KS, Lee SB, Kang NG, Min DS, Kim YH, Ryu SH, Suh PG, Shin HS. 1997. Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. Nature 389:290-293.
48. Kind PC, Kelly GM, Fryer HJ, Blakemore C, Hockfield S. 1997. Phospholipase C-beta1 is present in the botrysome, an intermediate compartment-like organelle, and is regulated by visual experience in cat visual cortex. J Neurosci 17:1471-1480.
49. Kjelstrup KG, Tuvnes FA, Steffenach HA, Murison R, Moser EI, Moser MB. 2002. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci USA 99:10825-10830.
50. Kleinrok Z, Turski L, Wawtzyniak M, Cybaulska R. 1980. The locomotot and exploratory activides in rats after lesion of hippocampal pyramidal cells with kainic acid. Pol J Pharmacol Pharm 32:625-637.
51. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. 2004. Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res 122:24-34.
52. Laroche S, Redini-Del Negro C, Clements MP, Lynch MA. 1990. Long-term activation of phosphoinositide turnover associated with increased release of amino acids in the dentate gyrus and hippocampus following classical conditioning in the rat. Eur J Neurosci 2:534-543.
53. Lin XH, Kitamura N, Hashimoto T, Shirakawa O, Maeda K. 1999. Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia. Biol Psychiatry 46: 1665-1671.
54. Lipska BK, Jaskiw GE, Weinberger DR. 1994. The effects of combined prefrontal cortical and hippocampal damage on dopamine-related behaviors in rats. Pharmacol Biochem Behav 48:1053-1057.
55. Lopez-Figueroa AL, Norton CS, Lopez-Figueroa MO, Armellini-Dodel D, Burke S, Akil H, Lopez JF, Watson SJ. 2004. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 55:225-233.
56. Maren S. 1999. Neurotoxic basolateral amygdala lesions impair learning and memory but not the performance of conditional fear in rats. J Neurosci 19:8696-8703.
57. Maren S, Aharonov G, Fanselow MS. 1997. Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res 88:261-274.
58. Maren S, Fanselow MS. 1997. Electrolytic lesions of the fimbria/fornix, dorsal hippocampus, or entorhinal cortex produce anterograde deficits in contextual fear conditioning in rats. Neurobiol Learn Mem 67:142-149.
59. McOmish CE, Burrows E, Howard M, Shin H-S, Kim D, Scarr E, Dean B, van den Buuse M, Hannan AJ. 2007. Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration. Molecular Psychiatry (in press; 31 Jul 2007 Epub ahead of print).
60. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. 2001. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6:293-301.
61. Mundy WR, Tilson HA. 1988. Behavioral impairment in the rat after colchicine lesions of the hippocampus and nucleus basalis. Neurotoxicology 9:511-519.
62. Ni YG, Gold SJ, Iredale PA, Terwilliger RZ, Duman RS, Nestler EJ. 1999. Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: In vivo and in vitro studies. J Neurosci 19:3674-3680.
63. Nicolle MM, Colombo PJ, Gallagher M, McKinney M. 1999a. Metabotropic glutamate receptor-mediated hippocampal phosphoinositide turnover is blunted in spatial learning-impaired aged rats. J Neurosci 19:9604-9610.
64. Nicolle MM, Gallagher M, McKinney M. 1999b. No loss of synaptic proteins in the hippocampus of aged, behaviorally impaired rats. Neurobiol Aging 20:343-348.
65. Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR, Kleinman JE. 1997. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse 27:168-176.
66. Nomoto S, Adachi K, Yang LX, Hitata Y, Muraguchi S, Kiuchi K. 1997. Distribution of RGS4 mRNA in mouse brain shown by in situ hybridization. Biochem Biophys Res Commun 241:281-287.
67. Nudmamud-Thanoi S, Reynolds GP. 2004. The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci Lett 372:173-177.
68. O'Donovan MC, Williams NM, Owen MJ. 2003. Recent advances in the genetics of schizophrenia. Hum Mol Genet 12 Spec No 2:R125-R133.
69. Ohnuma T, Augood SJ, Arai H, McKenna PJ, Emson PC. 1998. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res Mol Brain Res 56:207-217.
70. Pantelis C, Barnes TR, Nelson HE, Tannet S, Weatherley L, Owen AM, Robbins TW. 1997. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120 (Pt 10):1823-1843.
71. Pantelis C, Stuart GW, Nelson HE, Robbins TW, Barnes TR. 2001. Spatial working memory deficits in schizophrenia: Relationship with tardive dyskinesia and negative symptoms. Am J Psychiatry 158:1276-1285.
72. Park S, Holzman PS. 1992. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49:975-982.
73. Park S, Holzman PS, Goldman-Rakic PS. 1995. Spatial working memory deficits in the relatives of schizophrenic patients. Arch Gen Psychiatry 52:821-828.
74. Paxinos G, Franklin KJ. 2001. The Mouse Brain in Stereotaxic Coordinates. New York: Academic Press.
75. Pitkanen A, Pikkarainen M, Nurminen N, Ylinen A. 2000. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann N Y Acad Sci 911:369-391.
76. Pouzet B, Feldon J, Veenman CL, Yee BK, Richmond M, Nicholas J, Rawlins P, Weiner I. 1999. The effects of hippocampal and fimbria-fornix lesions on prepulse inhibition. Behav Neurosci 113: 968-981.
77. Raedler TJ, Bymaster FP, Tandon R, Copolov D, Dean B. 2007. Towards a muscarinic hypothesis of schizophrenia. Mol Psychiatry 12:232-246.
78. Richmond MA, Yee BK, Pouzet B, Veenman L, Rawlins JN, Feldon J, Bannerman DM. 1999. Dissociating context and space within the hippocampus: Effects of complete, dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial learning. Behav Neurosci 113:1189-1203.
79. Rizig MA, McQuillin A, Puri V, Choudhury K, Datta S, Thirumalai S, Lawrence J, Quested D, Pimm J, Bass N, Lamb G, Moorey H, Badacsonyi A, Kelly K, Morgan J, Punukollu B, Kandasami G, Curtis D, Gurling H. 2006. Failure to confirm genetic association between schizophrenia and markers on chromosome 1q23.3 in the region of the gene encoding the regulator of G-protein signaling 4 protein (RGS4). Am J Med Genet B Neuropsychiatr Genet 141:296-300.
80. Rizk A, Curley J, Robertson J, Raber J. 2004. Anxiety and cognition in histamine H3 receptor -/- mice. Eur J Neurosci 19:1992-1996.
81. Rochford J, Beaulieu S, Rousse I, Glowa JR, Barden N. 1997. Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: Effects of diazepam and FG-7142. Psychopharmacology (Berl) 132:145-152.
82. Ross EM, Wilkie TM. 2000. GTPase-activating proteins for heterotrimeric G proteins: Regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69:795-827.
83. Sacchetti B, Lorenzini CA, Baldi E, Tassoni G, Bucherelli C. 1999. Auditory thalamus, dorsal hippocampus, basolateral amygdala, and perirhinal cortex role in the consolidation of conditioned freezing to context and to acoustic conditioned stimulus in the rat. J Neurosci 19:9570-9578.
84. Salles J, Wallace MA, Fain JN. 1993. Modulation of the phospholipase C activity in rat brain cortical membranes by simultaneous activation of distinct monoaminergic and cholinergic muscarinic receptors. Brain Res Mol Brain Res 20:111-117.
85. Sams-Dodd F, Lipska BK, Weinberger DR. 1997. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl) 132: 303-310.
86. Scarr E, Copolov DL, Dean B. 2001. A proposed pathological model in the hippocampus of subjects with schizophrenia. Clin Exp Pharmacol Physiol 28:70-73.
87. Seeman P, Lee T. 1975. Antipsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188:1217-1219.
88. Shin J, Kim D, Bianchi R, Wong RK, Shin HS. 2005. Genetic dissection of theta rhythm heterogeneity in mice. Proc Natl Acad Sci USA 102:18165-18170.
89. Sobell JL, Richard C, Wirshing DA, Heston LL. 2005. Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians. Am J Med Genet B Neuropsychiatr Genet 139:23-27.
90. Spires TL, Molnar Z, Kind PC, Cordery PM, Upron AL, Blakemore C, Hannan AJ. 2005. Activity-dependent regulation of synapse and dendritic spine morphology in developing barrel cortex requires phospholipase C-beta1 signalling. Cereb Cortex 15:385-393.
91. Swanson LW. 1977. The anatomical organization of septo-hippocampal projections. Ciba Found Symp (58):25-48.
92. Takenawa T, Homma Y, Emori Y. 1991. Properties of phospholipase C isozymes. Methods Enzymol 197:511-518.
93. Traynor JR, Neubig RR. 2005. Regulators of G protein signaling & drugs of abuse. Mol Interv 5:30-41.
94. Undie AS, Wang HY, Friedman E. 1995. Decreased phospholipase C-beta immunoreactivity, phosphoinositide metabolism, and protein kinase C activation in senescent F-344 rat brain. Neurobiol Aging 16:19-28.
95. van den Buuse M, Garner B, Gogos A, Kusljic S. 2005. Importance of animal models in schizophrenia research. Aust N Z J Psychiatry 39:550-557.
96. Watanabe M, Nakamura M, Sato K, Kano M, Simon MI, Inoue Y. 1998. Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase C beta in mouse brain. Eur J Neurosci 10:2016-2025.
97. Watanabe S, Nishikawa T, Takashima M, Toru M. 1983. Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics. Life Sci 33:2187-2196.
98. Weeber EJ, Caldwell KK. 2004. Delay fear conditioning modifies phospholipase C-beta 1a signaling in the hippocampus and frontal cortex. Pharmacol Biochem Behav 78:155-164.
99. Weeber EJ, Savage DD, Sutherland RJ, Caldwell KK. 2001. Fear conditioning-induced alterations of phospholipase C-beta1a protein level and enzyme activity in rat hippocampal formation and medial frontal cortex. Neurobiol Learn Mem 76:151-182.
100. Williams LM, Das P, Harris AW, Liddell BB, Brammer MJ, Olivieri G, Skerrett D, Phillips ML, David AS, Peduto A, Gordon E. 2004. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 161:480-489.
101. Yilmazer-Hanke DM, Roskoden T, Zilles K, Schwegler H. 2003. Anxiety-related behavior and densities of glutamate, GABAA, acetylcholine and serotonin receptors in the amygdala of seven inbred mouse strains. Behav Brain Res 145:145-159.
102. Yuferov V, Kroslak T, Laforge KS, Zhou Y, Ho A, Kreek MJ. 2003. Differential gene expression in the rat caudate putamen after "binge" cocaine administration: Advantage of triplicate microarray analysis. Synapse 48:157-169.
103. Zhang F, St Clair D, Liu X, Sun X, Sham PC, Crombie C, Ma X, Wang Q, Meng H, Deng W, Yates P, Hu X, Walker N, Murray RM, Collier DA, Li T. 2005. Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia. Genes Brain Behav 4:444-448.